• Addition Therapeutics Inks $100 Million Funding
  • Solve Therapeutics Secures $120 Million
  • Solve Therapeutics Raises $120M in Oversubscribed Funding Round
  • Addition Therapeutics Secures $100M Funding to Advance Genomic Medicine
  • R1 Therapeutics raises $77.5M Series A to advance kidney disease drug
Abingworth - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    207 followers

  • Elon Musk

    Elon Musk

    79 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    56 followers

  • Jack Dorsey

    Jack Dorsey

    39 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    209 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeAbingworth
Abingworth logo

Abingworth

0 followers

About Abingworth

Abingworth is a trans-atlantic bio-science investment firm that works with entrepreneurs to turn breakthrough science into breakthrough medicine. With over thirty years of experience, they have invested in over a hundred young companies and helped them navigate through various scenarios to build successful companies.

Recent News

Addition Therapeutics Inks $100 Million Funding

Solve Therapeutics Secures $120 Million

Recent Deals

Solve Therapeutics Raises $120M in Oversubscribed Funding Round

November 17, 2025

Addition Therapeutics Secures $100M Funding to Advance Genomic Medicine

December 17, 2025

R1 Therapeutics Raises $77.5M Series A to Advance Kidney Disease Drug

March 18, 2026

Key Facts

HQ Location

London, United Kingdom

Founded

1973

Employees

11 - 50

Status

Investor

Investor Type

Venture Investor

Website

https://abingworth.com